Cellular Therapy & Immunobiology Working Party (CTIWP)
Study type:
Study number:
8420041
Type of treatment:
CAR T
Gene Therapy
Cellular therapies (other than DLI)
Diseases:
All diseases
Short title:
Primary objective:
Key inclusion criteria:
Facility (operations) managers, production (operations) managers, quality assurance managers and quality control managers engaged in cell and gene therapy activities.
Country:
All EBMT member countries
Principal investigator:
EBMT Study Unit:
Leiden Study Unit
Reason for processing personal data:
Not applicable to surveys
Categories of personal data collected:
Not applicable to surveys
Recipients who may access the data:
Not applicable to surveys
3rd-party processors of Personal Data on behalf of EBMT/Service provider:
Not applicable to surveys
Privacy notices
Article 6 lawful basis for processing personal data:
Article 6.1 (a) - Consent (Collection)
Article 9 basis for processing special category data:
Article 9(2) (a) - Consent (Collection)
Data Protection Impact Assessments
Rights available to individuals:
Access
Data portability
Rectification
Objection
Deletion
Is a Data Protection Impact Assessment required?:
Not applicable to surveys
Retention Schedule (if possible):
Not applicable to surveys